KAMBRIA WARNOCK: Open Payments
NPI 1801668447 · BETHEL PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,100 in 78 payments from 23 companies in 2025. Trend: 2023 $121 · 2024 $364 · 2025 $2,100
Food & beverage: $2,100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $379 |
| Amgen Inc. | 9 | $360 |
| Otsuka America Pharmaceutical, Inc. | 5 | $298 |
| Novo Nordisk Inc | 14 | $233 |
| AstraZeneca Pharmaceuticals LP | 3 | $200 |
| GlaxoSmithKline, LLC. | 4 | $98 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| PFIZER INC. | 3 | $58 |
| Lundbeck LLC | 2 | $48 |
| Astellas Pharma US Inc | 2 | $41 |
Products named: REXULTI, OTEZLA, QULIPTA, BREZTRI, Wegovy, AIRSUPRA, UBRELVY, JARDIANCE.
Industry payments across PA — which companies pay providers there.
